Moreover, combining both arms of the drug is justified best in this case by our research question, which investigates the overall effect of the GLP-1 receptor agonists in PD treatment, not to compare the effect of different doses of one drug in this drug family
The model wasnt wrong, but was incomplete
In other words, its not just a fat-versus-muscle test, but a visceral fat scan as well, pinpointing the amount of fat surrounding your organs
Before we go into how are these, uh, typically prescribed and, and what you should be aware of and what you should be testing for
Poly-agonists : Drugs combining GLP-1 with other hormones (GIP, glucagon, amylin) to potentially increase weight loss